tiprankstipranks
Advertisement
Advertisement
Enliven price target lowered to $78 from $80 at Guggenheim
PremiumThe FlyEnliven price target lowered to $78 from $80 at Guggenheim
14d ago
Enliven price target raised to $80 from $67 at Goldman Sachs
Premium
The Fly
Enliven price target raised to $80 from $67 at Goldman Sachs
14d ago
Enliven price target raised to $68 from $55 at Clear Street
Premium
The Fly
Enliven price target raised to $68 from $55 at Clear Street
14d ago
Enliven price target raised to $70 from $45 at JonesResearch
PremiumThe FlyEnliven price target raised to $70 from $45 at JonesResearch
2M ago
Enliven Therapeutics Prices Upsized Public Equity Offering
Premium
Company Announcements
Enliven Therapeutics Prices Upsized Public Equity Offering
2M ago
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
Premium
Market News
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
2M ago
Boris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
PremiumRatingsBoris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
2M ago
Enliven rises 14.8%
Premium
The Fly
Enliven rises 14.8%
2M ago
Enliven advances ELVN-001 with positive Phase 1 data
Premium
Company Announcements
Enliven advances ELVN-001 with positive Phase 1 data
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100